| UniProt ID | PRP17_HUMAN | |
|---|---|---|
| UniProt AC | O60508 | |
| Protein Name | Pre-mRNA-processing factor 17 | |
| Gene Name | CDC40 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 579 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Associates with the spliceosome late in the splicing pathway and may function in the second step of pre-mRNA splicing.. | |
| Protein Sequence | MSAAIAALAASYGSGSGSESDSDSESSRCPLPAADSLMHLTKSPSSKPSLAVAVDSAPEVAVKEDLETGVHLDPAVKEVQYNPTYETMFAPEFGPENPFRTQQMAAPRNMLSGYAEPAHINDFMFEQQRRTFATYGYALDPSLDNHQVSAKYIGSVEEAEKNQGLTVFETGQKKTEKRKKFKENDASNIDGFLGPWAKYVDEKDVAKPSEEEQKELDEITAKRQKKGKQEEEKPGEEKTILHVKEMYDYQGRSYLHIPQDVGVNLRSTMPPEKCYLPKKQIHVWSGHTKGVSAVRLFPLSGHLLLSCSMDCKIKLWEVYGERRCLRTFIGHSKAVRDICFNTAGTQFLSAAYDRYLKLWDTETGQCISRFTNRKVPYCVKFNPDEDKQNLFVAGMSDKKIVQWDIRSGEIVQEYDRHLGAVNTIVFVDENRRFVSTSDDKSLRVWEWDIPVDFKYIAEPSMHSMPAVTLSPNGKWLACQSMDNQILIFGAQNRFRLNKKKIFKGHMVAGYACQVDFSPDMSYVISGDGNGKLNIWDWKTTKLYSRFKAHDKVCIGAVWHPHETSKVITCGWDGLIKLWD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSAAIAALA ------CHHHHHHHH | 26.80 | 20068231 | |
| 11 | Phosphorylation | AIAALAASYGSGSGS HHHHHHHHHCCCCCC | 25.15 | 30108239 | |
| 12 | Phosphorylation | IAALAASYGSGSGSE HHHHHHHHCCCCCCC | 15.58 | 30108239 | |
| 14 | Phosphorylation | ALAASYGSGSGSESD HHHHHHCCCCCCCCC | 22.89 | 24043423 | |
| 16 | Phosphorylation | AASYGSGSGSESDSD HHHHCCCCCCCCCCC | 40.62 | 24043423 | |
| 18 | Phosphorylation | SYGSGSGSESDSDSE HHCCCCCCCCCCCCC | 35.31 | 24043423 | |
| 20 | Phosphorylation | GSGSGSESDSDSESS CCCCCCCCCCCCCCC | 44.08 | 24043423 | |
| 22 | Phosphorylation | GSGSESDSDSESSRC CCCCCCCCCCCCCCC | 52.92 | 24043423 | |
| 24 | Phosphorylation | GSESDSDSESSRCPL CCCCCCCCCCCCCCC | 43.24 | 30108239 | |
| 26 | Phosphorylation | ESDSDSESSRCPLPA CCCCCCCCCCCCCCH | 27.34 | 30108239 | |
| 27 | Phosphorylation | SDSDSESSRCPLPAA CCCCCCCCCCCCCHH | 33.57 | 30108239 | |
| 36 | Phosphorylation | CPLPAADSLMHLTKS CCCCHHHHHHHHHCC | 23.90 | 26074081 | |
| 41 | Phosphorylation | ADSLMHLTKSPSSKP HHHHHHHHCCCCCCC | 18.13 | 26074081 | |
| 43 | Phosphorylation | SLMHLTKSPSSKPSL HHHHHHCCCCCCCCE | 25.44 | 29255136 | |
| 45 | Phosphorylation | MHLTKSPSSKPSLAV HHHHCCCCCCCCEEE | 59.07 | 29255136 | |
| 46 | Phosphorylation | HLTKSPSSKPSLAVA HHHCCCCCCCCEEEE | 52.55 | 29255136 | |
| 47 | Acetylation | LTKSPSSKPSLAVAV HHCCCCCCCCEEEEE | 42.85 | 26051181 | |
| 49 | Phosphorylation | KSPSSKPSLAVAVDS CCCCCCCCEEEEECC | 32.47 | 30278072 | |
| 56 | Phosphorylation | SLAVAVDSAPEVAVK CEEEEECCCCCEEEC | 38.84 | 25159151 | |
| 81 | Phosphorylation | PAVKEVQYNPTYETM HHHCEEECCCCCCCC | 28.43 | - | |
| 84 | Phosphorylation | KEVQYNPTYETMFAP CEEECCCCCCCCCCC | 30.28 | 28796482 | |
| 85 | Phosphorylation | EVQYNPTYETMFAPE EEECCCCCCCCCCCC | 15.62 | 28796482 | |
| 87 | Phosphorylation | QYNPTYETMFAPEFG ECCCCCCCCCCCCCC | 13.74 | 28796482 | |
| 114 | Phosphorylation | PRNMLSGYAEPAHIN CCCHHHCCCCCHHHC | 12.38 | 27642862 | |
| 131 | Phosphorylation | MFEQQRRTFATYGYA HHHHHHHHHHHCCEE | 21.58 | 28555341 | |
| 134 | Phosphorylation | QQRRTFATYGYALDP HHHHHHHHCCEECCC | 17.18 | 29978859 | |
| 135 | Phosphorylation | QRRTFATYGYALDPS HHHHHHHCCEECCCC | 12.52 | 29978859 | |
| 137 | Phosphorylation | RTFATYGYALDPSLD HHHHHCCEECCCCCC | 8.12 | 29978859 | |
| 142 | Phosphorylation | YGYALDPSLDNHQVS CCEECCCCCCCCCCC | 48.28 | 28555341 | |
| 170 | Phosphorylation | QGLTVFETGQKKTEK CCCEEEECCCCHHHH | 33.19 | 28555341 | |
| 175 | Phosphorylation | FETGQKKTEKRKKFK EECCCCHHHHHHHHC | 54.50 | 28555341 | |
| 187 | Phosphorylation | KFKENDASNIDGFLG HHCCCCCCCCCCCHH | 36.86 | 20068231 | |
| 198 | Ubiquitination | GFLGPWAKYVDEKDV CCHHHHHHHCCHHHC | 41.77 | 29967540 | |
| 222 | Ubiquitination | ELDEITAKRQKKGKQ HHHHHHHHHHHCCCC | 46.87 | 32015554 | |
| 226 | Acetylation | ITAKRQKKGKQEEEK HHHHHHHCCCCCCCC | 64.10 | 7910527 | |
| 228 | Acetylation | AKRQKKGKQEEEKPG HHHHHCCCCCCCCCC | 64.51 | 7910537 | |
| 244 | Ubiquitination | EKTILHVKEMYDYQG CCEEEEEEEEECCCC | 26.47 | 32015554 | |
| 268 | Phosphorylation | VGVNLRSTMPPEKCY CCCCCCCCCCHHHCC | 27.54 | 30576142 | |
| 307 | S-palmitoylation | SGHLLLSCSMDCKIK CCCEEHHEECCCEEE | 3.84 | 29575903 | |
| 311 | S-palmitoylation | LLSCSMDCKIKLWEV EHHEECCCEEEEEEE | 3.53 | 29575903 | |
| 314 | Acetylation | CSMDCKIKLWEVYGE EECCCEEEEEEECCH | 32.80 | 25953088 | |
| 380 | Ubiquitination | RKVPYCVKFNPDEDK CCCCEEEECCCCHHH | 35.54 | 29967540 | |
| 387 | Ubiquitination | KFNPDEDKQNLFVAG ECCCCHHHCCEEEEE | 38.75 | 29967540 | |
| 399 | Acetylation | VAGMSDKKIVQWDIR EEECCCCEEEEEECC | 53.77 | 18585733 | |
| 435 | Phosphorylation | DENRRFVSTSDDKSL ECCCCEEECCCCCCE | 21.34 | 21406692 | |
| 436 | Phosphorylation | ENRRFVSTSDDKSLR CCCCEEECCCCCCEE | 30.76 | 21406692 | |
| 440 | Ubiquitination | FVSTSDDKSLRVWEW EEECCCCCCEEEEEE | 57.28 | 24816145 | |
| 541 | Acetylation | IWDWKTTKLYSRFKA EEEECCHHHHHHHHH | 51.14 | 25953088 | |
| 544 | Phosphorylation | WKTTKLYSRFKAHDK ECCHHHHHHHHHCCC | 41.50 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRP17_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRP17_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRP17_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PRP19_HUMAN | PRPF19 | physical | 22365833 | |
| CCD12_HUMAN | CCDC12 | physical | 26344197 | |
| CRNL1_HUMAN | CRNKL1 | physical | 26344197 | |
| U5S1_HUMAN | EFTUD2 | physical | 26344197 | |
| ISY1_HUMAN | ISY1 | physical | 26344197 | |
| SF3B3_HUMAN | SF3B3 | physical | 26344197 | |
| SNW1_HUMAN | SNW1 | physical | 26344197 | |
| SRPK3_HUMAN | SRPK3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-16; SER-18;SER-20; SER-22 AND SER-24, AND MASS SPECTROMETRY. | |